Effects of ethanolic extract of Artemisia persica on scopolamine-induced cognitive impairment and anxiety in rats by Rabiei, Zahra et al.
J. Med. Plants 2020; 19(73): 133-142 
  
 
Journal of Medicinal Plants 
 
 
Journal homepage: www.jmp.ir 
 
 
Abbreviations: AD, Alzheimer disease; AChE, Acetylcholinesterase; SOD, Superoxide dismutase; GPx, Glutathione 
peroxidase; CAT, Catalase; ChAT, Choline acetyltransferase; BDNF, brain-derived neurotrophic factor 
* Corresponding author: doctor.setorgi@gmail.com 
doi: ...... 
Received 15 May 2018; Received in revised form 9 July 2019; Accepted: 9 July 2019 
© 2020. Open access. This article is distributed under the terms of the Creative Commons Attribution 4.0 
International License (https://creativecommons.org/licenses/by-nc/4.0/) 
Research Article 
Effects of ethanolic extract of Artemisia persica on scopolamine-induced cognitive 
impairment and anxiety in rats  
Zahra Rabiei1, Rayhaneh Joodaki2, Mahbubeh Setorki2,* 
1Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, 
Shahrekord, Iran  
2Department of Biology, Izeh Branch, Islamic Azad University, Izeh, Iran 
ARTICLE INFO  ABSTRACT
Keywords: 
Artemisia persica 
Anxiety 
Avoidance memory 
 Background: Artemisia persica is used as an antiseptic, carminative, appetizer, 
antiparasitic, and antipyretic agent as well as to relieve fascial pains, and in the past, 
was used to relieve neuropathic pain and facilitate uterine contractions during 
childbirth. Objective: The aim of this study was to investigate the antioxidant 
potential and effects of A. persica on scopolamine-induced cognitive impairments and 
anxiety. Methods: In this experimental study, 50 male rats were randomly divided 
into 5 groups of 10 each, including control group, scopolamine (0.7 mg/kg, 
intraperitoneal injection) group, and three groups receiving scopolamine and 
ethanolic Artemisia persica extract (100, 200, and 400 mg/kg). After three weeks of 
treatment, behavioral tests including passive avoidance memory, plus maze test, and 
rotarod test were conducted. The level of malondialdehyde and the antioxidant 
capacity of the serum and brain in the rats were measured. Results: Treatment with 
A. persica extract at 100, 200, and 400 mg/kg in rats receiving scopolamine caused a 
significant increase in secondary latency in shuttle Box test (P < 0.01). Treatment of 
rats receiving scopolamine with A. persica extract at 100, 200, and 400 mg/kg 
significantly decreased the time elapsed in closed arms and significantly increased the 
time elapsed in the open arms in plus maze test (P < 0.05). Conclusion: The results 
of this study indicate that A. persica can act as a potent neuropharmacologic agent 
against cognitive impairment by modulating cholinergic activity and neuritis in the rat 
hippocampus. 
 
1. Introduction 
Alzheimer's disease (AD) is the most common 
neurological disorder and accounts for about two 
thirds of all dementia cases. AD is associated 
with cognitive and behavioral disorders. Non-
cognitive symptoms such as distress, aggression, 
depression, anxiety and insanity are seen in most 
patients with AD [1]. 
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The neurochemical analyses of brain tissues in 
AD patients have shown a significant decrease in 
the cortical cholinergic neurons, as well as 
cholinergic defects in the cortex and the 
hippocampus [2]. 
Acetylcholinesterase (AChE) is a goal in the 
treatment of AD, and inhibiting the activity of 
this enzyme to maintain the level of AChE in 
neuronal synapses has positive effects in AD 
patients. Evidence suggests that AChE inhibitors 
reduce the excess metabolism of synaptic ACh, 
and high levels of ACh in the synaptic cleft of 
post-synaptic movements. Memory deficits 
caused by cholinergic deficiency are associated 
with increased oxidative stress following 
scopolamine treatment [3]. 
However, a strong correlation was observed 
between scopolamine-induced memory deficits 
and oxidative stress in the hippocampus in a rat 
model of scopolamine-induced cognitive 
impairments. Reduced activity of antioxidant 
enzymes such as superoxide dismutase (SOD), 
glutathione peroxidase (GPx), and catalase 
(CAT) in the early stages of AD has been 
reported [5, 6]. Scopolamine is a muscarinic 
receptor antagonist, which causes transient 
memory deficit and induces a pattern similar to 
that of AD in animals [7]. 
Due to the high prevalence of central nervous 
system disorders, including AD, and the lack of 
definite treatment for these diseases, as well as 
the side effects due to chemical drugs and their 
inappropriate use, studies are being conducted 
with the aim of finding compounds with 
appropriate efficacy [8]. 
Dermaneh Irani, botanically called Artemisia 
persica, is one of the most valuable medicinal 
plants. A. persica is herbaceous, perennial, and self 
growing plant of the Cichorium family, that 
reaches a height of 90-120 cm, and grows in snowy 
highlands of Iran. Its compounds include essential 
oils, minerals, resins, santonin, volatile fatty acids, 
and artemisinin. A. persica is used as an antiseptic, 
carminative, appetizer, antiparasitic, and 
antipyretic agent as well as to relieve fascial pains, 
and in the past, was used to relieve neuropathic pain 
and facilitate uterine contractions during childbirth 
[9]. 
In vitro studies have shown antioxidant [10] 
anticancer [11], anti-bacterial, antifungal [12], 
antiviral [13] and antimalarial [14] effects of this 
plant. 
Although the protective effects of A. persica 
on the nervous system have not yet been 
investigated, the protective effects of other plants 
of the Artemisia genus on the nervous system 
have been shown, for example, the activity of 
monoamine oxidase inhibitor in the rat brain by 
Artemisia vulgaris [15], the protective effects of 
Artemisia absinthium against global brain 
ischemia [16], the protective effects of Artemisia 
asiatica against the damage to PC12 by the 
amyloid plaque [17], and the benzodiazepine-
like activity of the Artemisia herba-alba 
flavonoids on the GABA receptors [18]. 
Although the identified compounds from  
A. persica had significant activity in AD, there is 
no study clarifying the possible cognitive-
enhancing and antioxidant potentials of the extract 
from A. persica in a rat model of scopolamine. 
Therefore, we investigated the possible memory-
enhancing effects of the extract from A. persica in 
memory-impaired rats and its possible mechanism 
on the levels of biochemical parameters in the rat 
hippocampus of the scopolamine model. 
 
2. Materials and Methods 
2.1. Preparation of Artemisia persica Extract 
Dried A. persica was purchased from the 
groceries of the Izeh city, and after being 
identified as the plant of interest by a botanist, 
was registered at the Herbarium of Islamic Azad 
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University, Izeh Branch (herbarium number: 
566). The dried leaves were pulverized and then 
placed in 70% ethanol. 
The glass flask containing the plant was 
placed on a magnetic shaker and then left at room 
temperature for 72 hours. The contents were then 
filtered and the solution was kept at 37 ºC to 
allow water and alcohol to evaporate so that the 
extract was dried then kept at -20 ºC until use 
(yielded 32%). A. persica extract was dissolved 
in saline. 
 
2.2. Evaluation of in vitro antioxidant activity of 
Artemisia persica 
DPPH radical scavenging activity: Briefly, 1 
mL of 0.1 mM DPPH solution (prepared in 95% 
ethanol) was added to 1 mL of extract at different 
concentrations (50-300 µg/mL) and incubated for 
15 min in the darkness at room temperature, and 
then the absorbance was read at 517 nm against 
blank sample. The blank sample was prepared 
using distilled water instead of the extract. DPPH 
radical scavenging activity was calculated using 
the following formula: 
DPPH radical scavenging activity (%) = [(Ablank - 
Asample) /Ablank]× 100 
IC50 value obtained by plotting a graph of 
concentration (X-axis) against the percentage of 
inhibition (Y-axis) [19]. 
 
2.3. Grouping and treatment of rats 
Male rats were kept under the same conditions 
(21 ± 2 ºC, 12 hour light/12 hour darkness cycle, 
and free access to the same water and food). 
The male Wistar rats were randomly assigned 
into 5 groups of 10 each. The control group was 
injected with normal saline (1 mg/kg) for 21 
days. 
The scopolamine group received scopolamine 
at 0.7 mg/kg for 21 days. 
The experimental groups received 
scopolamine and then the A. persica extract at 
100, 200 and 400 mg/kg through intraperitoneal 
injection for 21 days. 
After the treatment period was completed, 
behavioral tests were conducted. Then, the 
samples of blood and brain tissue were collected 
as the rats were under deep anesthesia, and then 
were prepared for later examinations. 
 
2.3.1. Passive avoidance memory 
Passive avoidance memory was measured by 
shuttle box. This apparatus has a bright chamber 
connected to a dark chamber by a guillotine door. 
Electric shocks are exerted to a conductive metal 
grid on the floor of the apparatus by a separate 
stimulus. This test was performed on each rat for 
four consecutive days. On the first two days, rats 
were individually allowed to freely explore the 
apparatus for 5 min. On the third day, an 
acquisition test was conducted. Rats were left in 
the bright chamber and, after 2-minute 
acclimatization, the guillotine door was opened 
and after the rat entry into the dark chamber, it 
was closed and an electrical shock  
(2 mA/second) was exerted to rat and the latency 
to enter the dark chamber was recorded as initial 
latency. Twenty-four hours later, each rat was 
placed in the bright chamber and latency to enter 
the dark chamber was measured as secondary 
latency (up to 60 seconds) [20]. 
 
2.3.2. Rotarod performance test 
The ability to maintain balance and motor 
resistance was investigated using rotarod. This 
apparatus has a rod that rotates at a speed of 0-40 
rpm. The apparatus also has a belt and the speed 
of the rod can be adjusted by changing the belt 
position. First, the animal was placed on the 
rotating rod of the apparatus and trained to walk 
on it according to the main protocol (10 rpm and 
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7 rpm2 acceleration). Thirty min later, the rat was 
again placed on the rod and the time to maintain 
balance and resist rod movement was recorded. 
The maximum time for each animal in this test 
was considered to be 300 sec [20]. 
 
2.3.3. Elevated plus maze (EPM) test 
An apparatus called elevated plus maze was 
used to measure anxiety. This apparatus has two 
opposite open arms, two opposite closed arms, 
and a central sheath elevated 50 cm above the 
floor. This test was performed in a relatively 
dark, silent chamber, and each animal was placed 
gently in the center of the device facing the open 
arm and allowed to explore for 5 min. The 
number of entries and time spent in each arm 
were recorded [20]. 
 
2.4. Measuring serum MDA level 
Briefly, 0.5g of thiobarbituric acid was mixed 
with 80ml of acetic acid 20% and the pH of the 
resulting mixture set at 3.5 by adding sodium 
hydroxide and its volume diluted with 100 ml 
acetic acid 20%. 100μl of serum sample was 
mixed with 100μl of SDS solution 1.8% and 
2.5ml of stock solution. Samples were placed in 
water bath for 1 hour, and then cooled and 
centrifuged at 4000 rpm. The optical absorbance 
of the supernatant was read at 523-nm 
wavelength [21]. 
 
2.5. Measuring brain MDA level 
One g of brain tissue was homogenized in 
cooled KCl 2.5% at 1:10 (weight-volume) and 
incubated in a metabolic incubator shaker at  
37 ± 1 ºC for 60 min. Then, 1 ml of 
tetrachloroacetic acid 5 % and 1 ml thiobarbituric 
acid 67 % were added and finely mixed. The 
solution of each vial was centrifuged at 2000 rpm 
for 15 min. Then, the supernatant was transferred 
to another tube and placed in water bath. After 10 
minutes, test tubes were cooled and optical 
absorbance read at 535-nm wavelength [21]. 
 
2.6. Measuring serum and brain ferric reducing 
ability of plasma (FRAP) 
Three solutions consisting of 1: a buffer  
(1.55 ml of sodium acetate and 8ml of concentrated 
acetic acid diluted with distilled water to a final 
volume of 500 ml), 2: iron chloride solution [270 mg 
of iron (III) chloride diluted with distilled water to a 
final volume of 50 ml], and 3: triazine solution (47 
mg of triazine dissolved in 40ml of 40 mM 
hydrochloric acid) were used to measure the 
antioxidant capacity in serum and brain. Stock 
solution was prepared by adding 10ml of the 
solution 1, one ml of the solution 2, and one ml of 
the solution 3. Twenty five µl of serum or brain 
homogenate was added to 1.5 ml of stock solution 
and the resulting solution left at 37 ºC for 10 
minutes. Optical absorbance was then read at 593 
nm wavelength [21]. 
 
2.7. Statistical analysis 
Data were analyzed using SPSS version 20. 
Analysis of Variance (ANOVA) followed by 
Tukey test used to identify statistical differences 
between means. All data were presented as mean 
± SD and P value less than 0.05 was considered 
statistically significant. 
 
3. Results 
In the present study antioxidant activity of 
Artemisia persica extract was evaluated and the 
results showed that Artemisia persica has a strong 
removing activity against DPPH-free radicals (IC50 
= 98.80 µg/ml). 
The results on the duration of the initial and 
secondary latency in the passive avoidance memory 
test in the studied groups are illustrated in Fig. 1.
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Fig. 1. Comparison of the duration of the primary (t1) and secondary (t2) latency in the passive avoidance 
memory test between studied groups; *** significant difference (P < 0.001); ** significant difference (P < 0.01); AP: 
Artemisia persica 
 
Table 1. Comparison of the mean (± standard deviation) duration of balance maintenance in Rotarod test between 
studied groups 
Time on rotarod Experimental groups 
24.88 ± 13.24 scopolamine 
50.75 ± 25.18 control 
18.71 ± 9.3 Scopolamine + AP100 
53.43 ± 50.67 Scopolamine + AP200 
51.14 ± 35.01 Scopolamine + AP400 
 
According to the results, there was no 
significant difference in the primary latency to 
enter the dark chamber between the studied 
groups (F = 1.398). Secondary latency duration 
was significantly lower in the scopolamine 
receiving group (F = 8.103) than in the control 
group (P < 0.001). Treatment with A. persica 
extract at 100, 200 and 400 mg/kg significantly 
increased the latency duration in the rats given 
scopolamine (P < 0.01). 
The results regarding the duration of balance 
maintenance in the Rotarod test in the studied 
groups are shown in Table 1. According to the 
results, there was no significant difference between 
the studied groups (F = 2.226) (P > 0.05). 
As illustrated in Fig. 2, scopolamine treatment 
in rats caused a significant increase in the time 
elapsed in the closed arms (F = 5.118) and a 
significant decrease in the time elapsed in the 
open arms (F = 31.91) of the elevated plus-maze 
device. Treatment with A. persicaextract at 200 
and 400 mg/kg of in the scopolamine receiving 
rats caused a significant decrease in elapsed time 
in closed arms and a significant increase in 
elapsed time in open arms in the elevated plus-
maze (P< 0.05). 
According to the Table 2, scopolamine 
treatment significantly increased MDA levels in 
the serum (F = 10.44) and brain (F = 12.73) tissue 
in the rats (P < 0.01). The treatment with the A. 
persica extract at the three doses did not cause a 
significant decrease in the serum and brain MDA 
levels compared to the scopolamine receiving 
group. 
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According to the results of Table 3, the 
antioxidant capacity of the brain (F = 35.75) and 
serum (F = 13.89) significantly decreased in the 
rats treated with scopolamine. The treatment with 
the A. persica extract at the three doses did not 
cause a significant increase in the antioxidant 
capacity of the serum and brain tissues compared 
to the group treated with scopolamine. 
 
B 
 
A 
 
Fig. 2. Comparison of the time elapsed in the open (A) and closed (B) arms in the elevated plus-maze device 
between studied groups; *** significant difference (P < 0.001);** significant difference (P < 0.01), * significant 
difference (P < 0.05). AP: Artemisiapersica 
 
Table 2. Comparison of the mean (± standard deviation) values of brain and serum malondialdehyde levels between 
studied groups 
MDA 
Experimental groups 
Brain Serum 
244.4 ± 57.96 362.1 ± 95.14 Scopolamine 
148.3 ± 33.55** 241.6 ± 27.51** Control 
243.3 ± 29.31 339.7 ± 34.90 Scopolamine + AP100 
220.9 ± 56.22 292.1 ± 68.46 Scopolamine + AP200 
302.5 ± 35.05 439.4 ± 54.04 Scopolamine + AP400 
** Significant difference (P < 0.01) 
 
Table 3. Comparison of mean (± standard deviation) values of antioxidant capacity of brain and serum between studied 
groups 
Antioxidant capacity 
Experimental groups 
Brain Serum 
241.5 ± 16.23 166.1 ± 47.34 Scopolamine 
364.3 ± 34.30*** 453.1 ± 142.9*** Control 
232.9 ± 17.5 163.7 ± 69.14 Scopolamine + AP100 
265 ± 61.68 256.4 ± 89.77 Scopolamine + AP200 
147.6 ± 34.55 203.3 ± 34.66 Scopolamine+ AP400 
*** Significant difference (P < 0.001) 
 
Effects of ethanolic extract …  Z. Rabiei, et al 
 
 
Journal of Medicinal Plants 139 March 2020, Vol. 19, No. 73: 133-142 
4. Discussion 
In this study, the neuroprotective effects of 
ethanol extract of A. persica on scopolamine-
induced learning and memory disorders were 
investigated. Treatment of rats with successive 
injections of scopolamine for 21 days resulted in 
a significant decrease in the secondary latency in 
the passive avoidance memory test. Scopolamine 
treatment also improved the anxiety behaviors in 
the plus maze test. A. persica extract significantly 
improved memory and anxiety in animals 
receiving scopolamine. Studies have shown that 
memory disorders caused by injection of 
scopolamine are associated with damage to 
cholinergic neurons and decreased levels of 
acetylcholine in the brain tissue. 
A possible mechanism by which A. persica 
extract can improve memory and learning 
disorders may be increase in the sensitivity of 
cholinergic receptors in the brain or a decrease in 
AChE activity.  The memory formed in the 
hippocampus is dependent on an increase in the 
level of extracellular acetylcholine (ACh). In 
addition, synaptic cholinergic transmission is 
impaired by the overexpression of 
acetylcholinesterase and decreased acetylcholine 
levels [22]. 
Studies have shown that Artemisia has potent 
anti-acetylcholinesterase properties in vitro [23]. 
A. persica has also been reported to increase the 
level of memory and learning through nicotinic 
and muscarinic receptors in human cortical tissue 
[24]. 
Studies have also shown that daily injection of 
scopolamine in rats with memory and learning 
impairment reduces the activities of choline 
acetyltransferase (ChAT) and brain-derived 
neurotrophic factor (BDNF) in the hippocampus 
[25]. BDNF is a protein that plays an important 
role in neuroprotection, neurogenicity, and 
synaptic plasticity, as well as in motor learning 
[26]. 
The level of this factor serves as a predictor of 
the development of neurodegenerative diseases, 
including AD [27]. 
Studies have shown that the ethanol extract of 
Artemisia increases the level of BDNF in the 
brain [28]. It seems that this plant can improve 
cognitive and behavioral disorders by affecting 
the factors that are effective on neurogenicity and 
synaptic plasticity. 
Scopolamine impairs memory and learning by 
increasing oxidative stress in the entire brain 
tissue, as well as in specific structures related to 
memory and learning. Scopolamine also 
eliminates the metabolism of low molecular 
weight antioxidants, especially glutathione, and 
exacerbates the lipid peroxidation in the brain 
tissue, which makes the brain susceptible to 
ROS-induced damage due to the high 
concentrations of unsaturated fatty acids with 
high oxidizing properties, such as arachidonic 
acid and docosanoic acid [21]. 
In the present study, injection of scopolamine 
caused a significant reduction in the antioxidant 
capacity of brain and serum and a significant 
increase in MDA level that is a lipid peroxidation 
marker. In the study of Rashidchet al. (2010), the 
antioxidant effects and phenolic and flavonoid 
contents of the methanol extract of Artemisia 
persica were evaluated. The antioxidant activity of 
the extract in inhibiting DPPH free radicals was 
also determined. 
In addition, the activity of the plant extract in 
inhibiting the oxidation of sunflower oil was 
determined by free fatty acid tests and lipid 
peroxidation marker. The results of these 
experiments showed that the plant extract had a 
strong antioxidant activity. The phenolic and 
flavonoid contents of the extract of the plant were 
407 and 308 mg/g, respectively [29]. 
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The results of antioxidant tests on the  
A. persica extract in this study confirmed that the 
plant had a high antioxidant property. The results 
regarding serum and brain tissue antioxidant 
capacity indicated that the extract did not have a 
significant effect on oxidative stress parameters 
of the serum and brain tissues and cognitive 
impairments might be improved through other 
mechanisms. 
 
5. Conclusion 
A. persica is found only in Iran and is used for 
a wide spectrum of purposes in traditional 
medicine. However, few studies have been 
conducted on neuroprotective effects of the plant 
in animal models as well as in clinical trials.  
There is very limited information on the plant's 
active ingredients and the mechanism of its 
neuroprotective effects, necessitating further 
research on this subject. A possible mechanism 
by which A. persica extract can improve memory 
and learning disorders may be increase in the 
sensitivity of cholinergic receptors in the brain or 
a decrease in AChE activity. 
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  واژگان:گل
Artemisa persica  
  ي احترازيحافظه
  اضطراب
 مسكنو  تببر ،يسرسكاآ نگلا ضد آور،شتها ا ،شكندباه،ضدعفونيكنندانبه عنودرمنه ايرانيمقدمه: 
 هتسهيل كنند انبه عنوو  عصبي يهادرد تسكين ايگذشته برو در  دميشو دهستفاا حشاييا يهادرد
اكسيداني، در مطالعات آزمايشگاهي اثرات آنتيند. دميكر دهستفاا نيمازا مهنگادر  حمر تنقباضاا
 :دفه ضدباكتريايي، ضدقارچي، ضدويروسي و ضدماالريايي اين گياه نشان داده شده است.ضدسرطاني، 
شناختي و  اختالالت ي ايراني براكسيداني و اثرات گياه درمنهپتانسيل آنتي بررسي هدف با حاضر مطالعه
موش صحرايي به  50 در مطالعه تجربي حاضر، :يبررس روش .شد انجام اسكوپوالمين از ناشي اضطراب
گرم بر ميلي 7/0كننده اسكوپوالمين (گروه كنترل، گروه دريافت شاملتايي  10 گروه 5صورت تصادفي به 
كننده اسكوپوالمين به همراه عصاره اتانولي گياه درمنه هاي دريافتكيلوگرم، تزريق داخل صفاقي) و گروه
هاي زمونآگرم بر كيلوگرم قرار گرفتند. پس از تيمار به مدت سه هفته، ميلي 400و  200، 100هاي در غلظت
دهيد آلديرفتاري شامل آزمون حافظه احترازي غيرفعال و آزمون پالس ميز و روتارود انجام شد. ميزان مالون
كننده اسكوپوالمين هاي دريافتتيمار موش :جينتا ها نيز تعيين شد.اكسيداني سرم و مغز موشيل آنتيو پتانس
ر داگرم بر كيلوگرم سبب افزايش معنيميلي 400و  200، 100هاي ي ايراني در غلظتتوسط عصاره درمنه
كننده اسكوپوالمين توسط هاي دريافت. تيمار موش)>01/0P(د شخير ثانويه در تست شاتل باكس أزمان ت
دار مدت زمان سپري ي ايراني با كاهش معنيگرم بر كيلوگرم عصاره درمنهميلي 400و  200هاي غلظت
دار مدت زمان سپري شده در بازوهاي باز دستگاه پالس ميز همراه شده در بازوهاي بسته و افزايش معني
تواند به عنوان يك دهد كه گياه درمنه ايراني ميمينتايج اين مطالعه نشان  :يريگجهينت .)>P 05/0( بود
عامل نوروفارماكولوژيك قوي در برابر اختالالت شناختي از طريق تعديل فعاليت كولينرژيك و التهاب 
  عصبي در هيپوكامپ موش صحرايي باشد.
 
